Immuron (IMRN) EBT Growth (1y) (2017 - 2025)
Powered by 
Analysis
Immuron (IMRN) EBT Growth (1y) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.54 Bn | 198.55 Bn | 7.24 Bn | 76.53% |
| 2 | Gilead Sciences | 186.84 Bn | 183.58 Bn | 6.22 Bn | -522.15% |
| 3 | Vertex Pharmaceuticals | 129.39 Bn | 121.54 Bn | 2.84 Bn | 8.48% |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.06 Bn | 3.93 Bn | 0.60% |
| 5 | Moderna | 69.00 Bn | 63.87 Bn | 52.00 Mn | 6.23% |
| 6 | Argenx Se | 61.15 Bn | 55.97 Bn | 1.37 Bn | 88.92% |
| 7 | Alnylam Pharmaceuticals | 32.67 Bn | 29.37 Bn | 992.69 Mn | 530.43% |
| 8 | Biogen | 32.37 Bn | 31.08 Bn | 1.96 Bn | -82.20% |
| 9 | Roivant Sciences | 28.18 Bn | 28.87 Bn | 1.16 Mn | - |
| 10 | Immuron | 7.25 Mn | -1.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 26.93% |
| Jun 30, 2024 | -269.06% |
| Dec 31, 2023 | -24.60% |
| Dec 31, 2022 | -14,819.74% |
| Dec 31, 2021 | 68.39% |
| Jun 30, 2021 | -236.53% |
| Dec 31, 2020 | -175.74% |
| Dec 31, 2019 | 99.04% |
| Dec 31, 2018 | -141.73% |
| Dec 31, 2017 | 47.76% |
API Access
Immuron EBT Growth (1y) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-growth-1y&ticker=IMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-growth-1y", "ticker": "IMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-growth-1y&ticker=IMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();